Contracts Signed on Sanofi and Boehringer Ingelheim Business Exchange
GLOBAL - Sanofi and Boehringer Ingelheim have announced the signing of contracts to secure the strategic transaction initiated in December 2015 which consists of an exchange of Sanofi’s animal health business (Merial) and Boehringer Ingelheim’s consumer healthcare (CHC) business.
30 June 2016
2 minute read
By: 
